Sign In
Buy BALY
$13.16
-0.360 (-2.66%)
At Close: Jun 03, 2026
These 4 Toxic Stocks May Bring Bad Luck to Your Portfolio
09:02am, Thursday, 19'th Jan 2023
Consider dumping toxic stocks like BALY, OMCL, ILMN and AY from your portfolio to avoid huge losses.
Build-A-Bear Workshop and Bally's have been highlighted as Zacks Bull and Bear of the Day
01:17pm, Tuesday, 17'th Jan 2023 Zacks Investment Research
Build-A-Bear Workshop and Bally's are part of the Zacks Bull and Bear of the Day article.
Bear of the Day: Bally's Corp. (BALY)
11:00am, Tuesday, 17'th Jan 2023 Zacks Investment Research
Bally's has recently been on the receiving end of negative earnings estimate revisions.
Implied Volatility Surging for Bally's (BALY) Stock Options
03:07pm, Monday, 16'th Jan 2023 Zacks Investment Research
Investors need to pay close attention to Bally's (BALY) stock based on the movements in the options market lately.
Why Now Is NOT the Time to Buy BALY Stock
11:36am, Monday, 16'th Jan 2023
Are you ready to spin the wheel and take a chance on Bally's (NYSE: BALY )? Not so fast, as BALY stock could continue to lose value in 2023.
Why You Should Invest $100 in BALY Stock Now
11:28am, Monday, 09'th Jan 2023
Are you ready to bet a C-note at Wall Street's huge casino? If so, feel free to give Bally's (NYSE: BALY ) stock a try.
Welcome Back, Goldilocks
09:00am, Sunday, 08'th Jan 2023
U.S. equity markets rallied on the first week of the year after employment data showed strong job growth alongside a cool down in wage pressures, reviving hopes of a 'soft landing'. After posting decl
Bally's Corporation (BALY) Q3 2022 Earnings Call Transcript
03:42pm, Sunday, 06'th Nov 2022
Bally's Corporation (NYSE:BALY ) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET Company Participants Lee Fenton - CEO Bobby Lavan - CFO George Papanier - President, Retail Robeson Reeves
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
02:06pm, Wednesday, 02'nd Nov 2022 Benzinga
Upgrades
According to Evercore ISI Group, the prior rating for BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) was changed from In-Line to Outperform. In the third quarter, BioCryst Pharmaceuticals showed
Civeo (CVEO) Q3 Earnings and Revenues Surpass Estimates
11:45am, Friday, 28'th Oct 2022 Zacks Investment Research
Civeo (CVEO) delivered earnings and revenue surprises of 39.13% and 6.15%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Bally's Corporation (BALY) Reports Next Week: Wall Street Expects Earnings Growth
02:02pm, Thursday, 27'th Oct 2022 Zacks Investment Research
Bally's (BALY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Analysts Have This to Say About Ballys
07:13pm, Tuesday, 25'th Oct 2022 Benzinga
Analysts have provided the following ratings for Ballys (NYSE:BALY) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
1
2
0
0
Last 30D
Bally's To Report Third Quarter 2022 Results On November 3, 2022
04:15pm, Monday, 24'th Oct 2022
PROVIDENCE, R.I., Oct. 24, 2022 /PRNewswire/ -- Bally's Corporation (NYSE: BALY) will release financial results for the third quarter 2022 prior to the market opening on Thursday, November 3, 2022.
Elevated Debt Makes Bally's Stock A Gamble
07:55am, Wednesday, 19'th Oct 2022
Bally's shares have performed poorly as worries about a recession and its debt outweigh its growth potential. Results are strong today, and online gambling combined with its Chicago project provides s
The record-breaking bet on sports gambling in California faces long odds
12:05pm, Monday, 10'th Oct 2022 MarketWatch
Despite about $400 million spent on campaigning, recent polls have shown that only about a third of Californians plan to vote for either proposition.
